The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Conduit Pharmaceuticals Repays $600,000 Promissory Note and Converts $1.7 Million Senior Secured Promissory Note
Feb 11, 2025•over 1 year ago
Contract Type
contract
BiotechnologyHealth CarePharmaceutical
Description
Conduit Pharmaceuticals announced the repayment of its $600,000 promissory note to Nirland Limited and the partial conversion of its $2.65 million senior secured promissory note with Nirland. The repayment of the promissory note fully satisfied all obligations under the agreement, while the conversion into shares of Conduit's common stock further reduced the company's debt obligations.
Company Information
Company
Conduit Pharmaceuticals
About
Conduit Pharmaceuticals Inc. is a pharmaceutical company with a unique business model focusing on bringing medicines to patients. Its approach addresses unmet medical needs and lengthens the intellectual property for existing assets through cutting-edge solid-form technology, and then commercializes these products with life science companies.
Predictive Intelligence
Strategic
ML-powered predictions for Conduit Pharmaceuticals's next move
